MedCap AB (publ) (FRA:61MA)

Market Cap	679.35M +26.6%
Revenue (ttm)	194.79M +16.6%
Net Income	20.31M +6.0%
EPS	1.36 +4.8%
Shares Out	n/a
PE Ratio	33.45
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	13
Open	44.40
Previous Close	44.25
Day's Range	44.40 - 44.40
52-Week Range	29.40 - 59.60
Beta	n/a
RSI	40.08
Earnings Date	Feb 6, 2026

About MedCap AB

MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout. It prefers to invest in healthcare equipment and services, biotechnology, life sciences, pharmaceuticals, med tech and assistive tech companies. The firm prefers to invest in small to medium size companies that are not listed on the stock exchange and are based in Nordic region and Northern Europe. It typically invests between SEK25 millio...

• Industry: Investors, not elsewhere classified
• Founded: 2001
• Employees: 592
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 61MA

Financial Performance

In 2025, MedCap AB's revenue was 2.11 billion, an increase of 16.64% compared to the previous year's 1.81 billion. Earnings were 219.80 million, an increase of 5.98%.

Financial numbers in SEK